PDE4D Polyclonal Antibody

$Mouse brain lysates probed with PDE4D Polyclonal Antibody, unconjugated (bs-1325R) at 1:300 overnight at 4\u00b0C followed by a conjugated secondary antibody at 1:10000 for 90 minutes at 37\u00b0C.$

Mouse brain lysates probed with PDE4D Polyclonal Antibody, unconjugated (bs-1325R) at 1:300 overnight at 4\u00b0C followed by a conjugated secondary antibody at 1:10000 for 90 minutes at 37\u00b0C.

Applications

WB
ELISA
FCM

Reactivity

Human
Mouse
Rat

Predicted Reactivity

Dog
Cow
Pig
Horse
Rabbit

Overview
Catalog #	bs-1325R
Product Name	PDE4D Polyclonal Antibody
Applications	WB, ELISA, FCM
Reactivity	Human, Mouse, Rat
Predicted Reactivity	Dog, Cow, Pig, Horse, Rabbit
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human PDE4D
Immunogen Range	401-550/809
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	5144
Subcellular location	Cytoplasm, Cell membrane
Synonyms	cAMP specic 3',5' cyclic phosphodiesterase 4D; DKFZp686M11213; FLJ97311; cAMP specic 3' 5' cyclic phosphodiesterase 4D; cAMP specic phosphodiesterase 4D; cAMP specic phosphodiesterase PDE4D; cAMP specic phosphodiesterase PDE4D6; cyclic AMP phosphodiesterase; DPDE 3; DPDE3; Dunce like phosphodiesterase E3; HSPDE4D; PDE 43; PDE43; PDE4DN2; Phosphodiesterase 4D cAMP specic dunce Drosophila homolog phosphodiesterase E3; Phosphodiesterase 4D cAMP specic phosphodiesterase E3 dunce homolog Drosophila; Phosphodiesterase 4D cAMP specic; Phosphodiesterase 4D, cAMP specic dunce; Phosphodiesterase E3 dunce homolog Drosophila; STRK 1; STRK1.
Background	Cyclic AMP-dependent phosphodiesterase type D (PDE4D) family is comprise of 5 variants (PDE4D1, D2, D3, D4 and D5). One or more PDE4D subtype variants are ubiquitously present in all mammalian cells. In CNS all five PDE4D subtype variants are expressed in varying ratios and their activity is regulated in tandem with GPCRs stimulation. Peripheral tissues also exhibit differential expression of PDE4D variants. PDE4D1/D2 mRNA levels rise in response to an increase in cAMP. Short term regulation of PDE4D variants involved PKA, MAP kinases and Erk2 phosphorylation that results in rapid change in their enzymatic activities. Other regulatory mechanism involved protein protein interactions with cytoskeletal scaffolding proteins.
Application Dilution
WB	1:300-5000
ELISA	1:500-1000
FCM	1:20-100

Applications

Reactivity

Predicted Reactivity

Search our catalog of hundreds of thousands of products